Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7
about
Dcas supports cell polarization and cell-cell adhesion complexes in developmentA new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseasesMolecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycleTransforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling componentExpression map of the human exome in CD34+ cells and blood cells: increased alternative splicing in cell motility and immune response genes.Cell migration and metastasis markers as targets of environmental pollutants and the Aryl hydrocarbon receptor.The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerAdaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis.Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
P2860
Q21136167-92E6687E-6965-4C16-B937-09091C8F70AEQ24656693-940E5DD2-BF1D-4132-9492-B598F4182E3FQ28085339-84688D95-9589-4762-A48D-FC2F98996458Q28241105-9FC7D8A8-BA3A-4CD8-948C-CD1E037E40D2Q28251271-324E05A6-331E-4AAE-AD67-B62771385603Q33529054-4B29A846-7A31-421C-B090-647243C95023Q33781097-91D1682C-4D2B-4B03-8391-C4E7BE91A39AQ34138871-DCF9FC81-D585-408A-8614-42C242A7203CQ34295621-E1FDA9B7-5CD6-4E07-94BE-0E8FA1A461F8Q34458459-521F6918-DD80-42E5-BFF0-B3287987E071Q34994783-CED83C7B-1610-4BB4-8F46-28CFF19489DDQ36060024-4B0F56EA-077A-4ADE-B915-629A298DF49FQ37832528-D5A6E946-8FDC-4B0E-A45C-90FF8DB3F257
P2860
Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@ast
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@en
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@nl
type
label
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@ast
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@en
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@nl
prefLabel
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@ast
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@en
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@nl
P2093
P2860
P3181
P356
P1433
P1476
Crk-associated substrate lymph ...... by inhibiting Smad6 and Smad7
@en
P2093
C Morimoto
H Kawasaki
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1209848
P407
P577
2007-02-08T00:00:00Z
P5875
P6179
1036150138